Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Biomedicines|May 25, 2024
Hotspot DNA Methyltransferase 3A (<i>DNMT3A</i>) and Isocitrate Dehydrogenase 1 and 2 (<i>IDH1/2</i>) Mutations in Acute Myeloid Leukemia and Their Relevance as Targets for ImmunotherapyNadine E Struckman, Rob C M de Jong, M Willy Honders, et al.Plos One|October 11, 2017
The epigenetic factor PCAF regulates vascular inflammation and is essential for intimal hyperplasia developmentRob C M de Jong, Mark M Ewing, Margreet R de Vries, et al.Circulation Research|August 3, 2014
Inhibition of 14q32 MicroRNAs miR-329, miR-487b, miR-494, and miR-495 increases neovascularization and blood flow recovery after ischemiaSabine M J Welten, Antonius J N M Bastiaansen, Rob C M de Jong, et al.Atherosclerosis|April 27, 2017
Inhibition of 14q32 microRNA miR-495 reduces lesion formation, intimal hyperplasia and plasma cholesterol levels in experimental restenosisSabine M J Welten, Rob C M de Jong, Anouk Wezel, et al.Journal for Immunotherapy of Cancer|December 9, 2024
DNA barcoded peptide-MHC multimers to measure and monitor minor histocompatibility antigen-specific T cells after allogeneic stem cell transplantationKyra J Fuchs, Marcus Göransson, Michel G D Kester, et al.Plos One|June 20, 2014
TLR4 accessory molecule RP105 (CD180) regulates monocyte-driven arteriogenesis in a murine hind limb ischemia modelAntonius J N M Bastiaansen, Jacco C Karper, Anouk Wezel, et al.Leukemia|December 13, 2025
A T-cell receptor targeting RUNX1 frameshift mutations in acute myeloid leukemiaNadine E Struckman, Georgia Koutsoumpli, Rob C M de Jong, et al.Cancers|November 13, 2021
An HLA-A*11:01-Binding Neoantigen from Mutated NPM1 as Target for TCR Gene Therapy in AMLDyantha I van der Lee, Georgia Koutsoumpli, Rogier M Reijmers, et al.Pageof 2